1. Home
  2. PII vs ADMA Comparison

PII vs ADMA Comparison

Compare PII & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polaris Inc.

PII

Polaris Inc.

HOLD

Current Price

$68.06

Market Cap

3.7B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.78

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PII
ADMA
Founded
1954
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.1B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
PII
ADMA
Price
$68.06
$19.78
Analyst Decision
Hold
Strong Buy
Analyst Count
11
2
Target Price
$52.80
$28.50
AVG Volume (30 Days)
788.8K
2.9M
Earning Date
01-27-2026
11-05-2025
Dividend Yield
3.94%
N/A
EPS Growth
N/A
205.35
EPS
N/A
0.86
Revenue
$7,076,200,000.00
$488,559,000.00
Revenue This Year
N/A
$22.19
Revenue Next Year
$0.13
$24.33
P/E Ratio
N/A
$23.11
Revenue Growth
N/A
27.63
52 Week Low
$30.92
$13.50
52 Week High
$75.25
$25.67

Technical Indicators

Market Signals
Indicator
PII
ADMA
Relative Strength Index (RSI) 56.06 66.02
Support Level $66.18 $19.13
Resistance Level $71.25 $20.22
Average True Range (ATR) 2.29 0.73
MACD 0.35 0.05
Stochastic Oscillator 62.55 79.44

Price Performance

Historical Comparison
PII
ADMA

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: